EBR Systems Inc Total Liabilities

Latest as of December 2025: AU$71.69 Million AUD ≈ $50.72 Million USD

EBR Systems Inc total liabilities. Based on the latest financial reports, EBR Systems Inc (EBR) has total liabilities worth AU$71.69 Million AUD (≈ $50.72 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check EBR Systems Inc (EBR) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of EBR Systems Inc (2019–2025)

Total liabilities of EBR Systems Inc from 2019 to 2025. This chart illustrates how EBR Systems Inc's total liabilities have evolved over time, based on quarterly financial data. Explore EBR Systems Inc long-term investment allocation to see how much of total assets are deployed in long-term investments.

EBR Systems Inc Competitors by Total Liabilities

The table below lists competitors of EBR Systems Inc ranked by their total liabilities.

Company Country Total Liabilities
Groupe Partouche SA
PA:PAR
France €100.64 Million
M.J. International Co Ltd
TW:8466
Taiwan NT$3.28 Billion
Grandstand Limited
NASDAQ:GRSD
USA $179.78 Million
City Of London Investment Trust
LSE:CTY
UK GBX164.23 Million
Regal Holding Co Ltd
TW:4807
Taiwan NT$940.14 Million
Bluerock Homes Trust Inc.
NYSE MKT:BHM
USA $452.66 Million
INmune Bio Inc
NASDAQ:INMB
USA $6.48 Million
Smr Utama Tbk
JK:SMRU
Indonesia Rp682.09 Billion

Liability Composition Analysis (2019–2025)

This chart breaks down EBR Systems Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see how large is EBR Systems Inc's balance sheet.

Liquidity & Leverage Metrics

EBR Systems Inc Total Liabilities Ratios Explained

EBR Systems Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 5.20 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio 0.41 Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 2.80 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.74 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how EBR Systems Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for EBR Systems Inc (2019–2025)

The table below shows the annual total liabilities of EBR Systems Inc from 2019 to 2025.

Year Total Liabilities Change
2025-12-31 AU$71.69 Million
≈ $50.72 Million
+45.69%
2024-12-31 AU$49.20 Million
≈ $34.81 Million
+2.85%
2023-12-31 AU$47.84 Million
≈ $33.85 Million
+72.53%
2022-12-31 AU$27.73 Million
≈ $19.62 Million
+191.09%
2021-12-31 AU$9.53 Million
≈ $6.74 Million
-79.31%
2020-12-31 AU$46.05 Million
≈ $32.58 Million
+75.67%
2019-12-31 AU$26.21 Million
≈ $18.55 Million
--

About EBR Systems Inc

AU:EBR Australia Medical Devices
Market Cap
$36.65 Million
AU$51.80 Million AUD
Market Cap Rank
#22838 Global
#817 in Australia
Share Price
AU$0.12
Change (1 day)
+0.00%
52-Week Range
AU$0.12 - AU$1.19
All Time High
AU$2.01
About

EBR Systems, Inc. develops implantable systems for wireless tissue stimulation. It offers WiSE cardiac resynchronization therapy system, an implantable cardiac pacing system able to provide stimulation to endocardial heart tissue for the correction of heart rhythm conditions without requiring the use of leads; and stimulation of the left ventricular endocardium for cardiac resynchronization thera… Read more